跳转至内容
Merck
CN
  • Acetylcholine controls GABA-, glutamate-, and glycine-dependent giant depolarizing potentials that govern spontaneous motoneuron activity at the onset of synaptogenesis in the mouse embryonic spinal cord.

Acetylcholine controls GABA-, glutamate-, and glycine-dependent giant depolarizing potentials that govern spontaneous motoneuron activity at the onset of synaptogenesis in the mouse embryonic spinal cord.

The Journal of neuroscience : the official journal of the Society for Neuroscience (2014-05-03)
Antonny Czarnecki, Hervé Le Corronc, Chiara Rigato, Barbara Le Bras, François Couraud, Anne-Laure Scain, Anne-Emilie Allain, Christine Mouffle, Erika Bullier, Jean-Marie Mangin, Pascal Branchereau, Pascal Legendre
摘要

A remarkable feature of early neuronal networks is their endogenous ability to generate spontaneous rhythmic electrical activity independently of any external stimuli. In the mouse embryonic SC, this activity starts at an embryonic age of ∼ 12 d and is characterized by bursts of action potentials recurring every 2-3 min. Although these bursts have been extensively studied using extracellular recordings and are known to play an important role in motoneuron (MN) maturation, the mechanisms driving MN activity at the onset of synaptogenesis are still poorly understood. Because only cholinergic antagonists are known to abolish early spontaneous activity, it has long been assumed that spinal cord (SC) activity relies on a core network of MNs synchronized via direct cholinergic collaterals. Using a combination of whole-cell patch-clamp recordings and extracellular recordings in E12.5 isolated mouse SC preparations, we found that spontaneous MN activity is driven by recurrent giant depolarizing potentials. Our analysis reveals that these giant depolarizing potentials are mediated by the activation of GABA, glutamate, and glycine receptors. We did not detect direct nAChR activation evoked by ACh application on MNs, indicating that cholinergic inputs between MNs are not functional at this age. However, we obtained evidence that the cholinergic dependency of early SC activity reflects a presynaptic facilitation of GABA and glutamate synaptic release via nicotinic AChRs. Our study demonstrates that, even in its earliest form, the activity of spinal MNs relies on a refined poly-synaptic network and involves a tight presynaptic cholinergic regulation of both GABAergic and glutamatergic inputs.

材料
产品编号
品牌
产品描述

Sigma-Aldrich
甘氨酸, ReagentPlus®, ≥99% (HPLC)
Sigma-Aldrich
甘氨酸, suitable for electrophoresis, ≥99%
Sigma-Aldrich
L-谷氨酸, ReagentPlus®, ≥99% (HPLC)
Sigma-Aldrich
甘氨酸, BioUltra, Molecular Biology, ≥99.0% (NT)
Sigma-Aldrich
甘氨酸, from non-animal source, meets EP, JP, USP testing specifications, suitable for cell culture, ≥98.5%
Sigma-Aldrich
γ-氨基丁酸, ≥99%
Sigma-Aldrich
氯化乙酰胆碱, ≥99% (TLC)
Sigma-Aldrich
L-谷氨酸, from non-animal source, meets EP testing specifications, suitable for cell culture, 98.5-100.5%
Sigma-Aldrich
甘氨酸 盐酸盐, ≥99% (HPLC)
SAFC
甘氨酸
Supelco
甘氨酸, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
L-谷氨酸, BioUltra, ≥99.5% (NT)
Supelco
γ-氨基丁酸, analytical standard
Sigma-Aldrich
甘氨酸, BioXtra, ≥99% (titration)
Sigma-Aldrich
甘氨酸, ACS reagent, ≥98.5%
Sigma-Aldrich
氯化乙酰胆碱, suitable for cell culture
Sigma-Aldrich
γ-氨基丁酸, BioXtra, ≥99%
Sigma-Aldrich
D -谷氨酸, ≥99% (TLC)
Sigma-Aldrich
碘化乙酰胆碱, ≥97%
Sigma-Aldrich
甘氨酸, 99%, FCC
Supelco
L-谷氨酸, Pharmaceutical Secondary Standard; Certified Reference Material
USP
甘氨酸, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
甘氨酸, meets analytical specification of Ph. Eur., BP, USP, 99-101% (based on anhydrous substance)
Sigma-Aldrich
氯化乙酰胆碱, pkg of 150 mg (per vial)
Sigma-Aldrich
甘氨酸, puriss. p.a., reag. Ph. Eur., buffer substance, 99.7-101% (calc. to the dried substance)
Sigma-Aldrich
1 M 甘氨酸 溶液
Sigma-Aldrich
L-谷氨酸, FCC
Sigma-Aldrich
L-谷氨酸 盐酸盐, ≥99% (HPLC)
USP
氯化乙酰胆碱, United States Pharmacopeia (USP) Reference Standard
谷氨酸, European Pharmacopoeia (EP) Reference Standard